Boston Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$2.27 M |
Shares Outstanding |
111.13 M |
Public Float |
61.2 M |
Address |
354 Merrimack Street No. 4 Lawrence Massachusetts 01843 United States |
Employees | - |
Website | http://www.bostonti.com |
Updated | 07/08/2019 |
Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. |